Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

CollPlant Biotechnologies (CLGN) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for CollPlant Biotechnologies (CLGN) over the last 7 years, with Q2 2025 value amounting to $0.28.

  • CollPlant Biotechnologies' EPS (Weighted Average and Diluted) fell 2432.43% to $0.28 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.51, marking a year-over-year decrease of 320.51%. This contributed to the annual value of -$1.44 for FY2024, which is 13252.53% down from last year.
  • Per CollPlant Biotechnologies' latest filing, its EPS (Weighted Average and Diluted) stood at $0.28 for Q2 2025, which was down 2432.43% from -$0.35 recorded in Q4 2024.
  • Over the past 5 years, CollPlant Biotechnologies' EPS (Weighted Average and Diluted) peaked at $0.88 during Q1 2021, and registered a low of -$0.44 during Q4 2023.
  • In the last 5 years, CollPlant Biotechnologies' EPS (Weighted Average and Diluted) had a median value of $0.33 in 2023 and averaged $0.16.
  • Within the past 5 years, the most significant YoY rise in CollPlant Biotechnologies' EPS (Weighted Average and Diluted) was 26666.67% (2021), while the steepest drop was 51428.57% (2021).
  • CollPlant Biotechnologies' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.3 in 2021, then tumbled by 30.0% to -$0.39 in 2022, then dropped by 14.1% to -$0.44 in 2023, then grew by 22.03% to -$0.35 in 2024, then skyrocketed by 180.7% to $0.28 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.28 in Q2 2025, compared to -$0.35 in Q4 2024 and $0.37 in Q2 2024.